119 related articles for article (PubMed ID: 7658913)
1. Enzymatic oxidation of the dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, into 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion.
Naoi M; Maruyama W; Zhang JH; Takahashi T; Deng Y; Dostert P
Life Sci; 1995; 57(11):1061-6. PubMed ID: 7658913
[TBL] [Abstract][Full Text] [Related]
2. A dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigro-striatal system of the human brain.
Maruyama W; Sobue G; Matsubara K; Hashizume Y; Dostert P; Naoi M
Neurosci Lett; 1997 Feb; 223(1):61-4. PubMed ID: 9058423
[TBL] [Abstract][Full Text] [Related]
3. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
Naoi M; Maruyama W; Nagy GM
Neurotoxicology; 2004 Jan; 25(1-2):193-204. PubMed ID: 14697894
[TBL] [Abstract][Full Text] [Related]
4. An endogenous dopaminergic neurotoxin, N-methyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells.
Maruyama W; Naoi M; Kasamatsu T; Hashizume Y; Takahashi T; Kohda K; Dostert P
J Neurochem; 1997 Jul; 69(1):322-9. PubMed ID: 9202326
[TBL] [Abstract][Full Text] [Related]
5. Oxidation of N-methyl(R)salsolinol: involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines.
Naoi M; Maruyama W; Kasamatsu T; Dostert P
J Neural Transm Suppl; 1998; 52():125-38. PubMed ID: 9564615
[TBL] [Abstract][Full Text] [Related]
6. A N-methyltransferase in human brain catalyses N-methylation of 1,2,3,4-tetrahydroisoquinoline into N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neurotoxin, N-methylisoquinolinium ion.
Naoi M; Matsuura S; Takahashi T; Nagatsu T
Biochem Biophys Res Commun; 1989 Jun; 161(3):1213-9. PubMed ID: 2742585
[TBL] [Abstract][Full Text] [Related]
7. Studies on the neurotoxicity of 6,7-dihydroxy-1-methyl-1,2,3,4-tetrahydroisoquinoline (salsolinol) in SH-SY5Y cells.
Willets JM; Lambert DG; Lunec J; Griffiths HR
Eur J Pharmacol; 1995 Dec; 293(4):319-26. PubMed ID: 8748684
[TBL] [Abstract][Full Text] [Related]
8. Dopamine-derived 1-methyl-6,7-dihydroxyisoquinolines as hydroxyl radical promoters and scavengers in the rat brain: in vivo and in vitro studies.
Maruyama W; Dostert P; Naoi M
J Neurochem; 1995 Jun; 64(6):2635-43. PubMed ID: 7760044
[TBL] [Abstract][Full Text] [Related]
9. A novel enzyme enantio-selectively synthesizes (R)salsolinol, a precursor of a dopaminergic neurotoxin, N-methyl(R)salsolinol.
Naoi M; Maruyama W; Dostert P; Kohda K; Kaiya T
Neurosci Lett; 1996 Jul; 212(3):183-6. PubMed ID: 8843103
[TBL] [Abstract][Full Text] [Related]
10. Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system.
Takahashi T; Deng Y; Maruyama W; Dostert P; Kawai M; Naoi M
J Neural Transm Gen Sect; 1994; 98(2):107-18. PubMed ID: 7734108
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of endogenous isoquinolines to human dopaminergic neuroblastoma SH-SY5Y cells.
Takahashi T; Maruyama W; Deng Y; Dostert P; Nakahara D; Niwa T; Ohta S; Naoi M
J Neural Transm (Vienna); 1997; 104(1):59-66. PubMed ID: 9085193
[TBL] [Abstract][Full Text] [Related]
12. Isoquinoline neurotoxins in the brain and Parkinson's disease.
Nagatsu T
Neurosci Res; 1997 Oct; 29(2):99-111. PubMed ID: 9359458
[TBL] [Abstract][Full Text] [Related]
13. N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study.
Maruyama W; Nakahara D; Ota M; Takahashi T; Takahashi A; Nagatsu T; Naoi M
J Neurochem; 1992 Aug; 59(2):395-400. PubMed ID: 1629715
[TBL] [Abstract][Full Text] [Related]
14. Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies.
Naoi M; Maruyama W; Dostert P; Hashizume Y; Nakahara D; Takahashi T; Ota M
Brain Res; 1996 Feb; 709(2):285-95. PubMed ID: 8833765
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of type A monoamine oxidase by 2(N)-methyl-6,7-dihydroxyisoquinolinium ions.
Naoi M; Maruyama W; Sasuga S; Deng Y; Dostert P; Ohta S; Takahashi T
Neurochem Int; 1994 Nov; 25(5):475-81. PubMed ID: 7849576
[TBL] [Abstract][Full Text] [Related]
16. Novel toxins and Parkinson's disease: N-methylation and oxidation as metabolic bioactivation of neurotoxin.
Naoi M; Maruyama W; Niwa T; Nagatsu T
J Neural Transm Suppl; 1994; 41():197-205. PubMed ID: 7931227
[TBL] [Abstract][Full Text] [Related]
17. N-methyl(R)salsolinol produces hydroxyl radicals: involvement to neurotoxicity.
Maruyama W; Dostert P; Matsubara K; Naoi M
Free Radic Biol Med; 1995 Jul; 19(1):67-75. PubMed ID: 7635360
[TBL] [Abstract][Full Text] [Related]
18. Oxidation of N-methyl-1,2,3,4-tetrahydroisoquinoline into the N-methyl-isoquinolinium ion by monoamine oxidase.
Naoi M; Matsuura S; Parvez H; Takahashi T; Hirata Y; Minami M; Nagatsu T
J Neurochem; 1989 Feb; 52(2):653-5. PubMed ID: 2911035
[TBL] [Abstract][Full Text] [Related]
19. Generation of reactive oxygen species accounts for cytotoxicity of an endogenous dopaminergic neurotoxin, (R)-N-methylsalsolinol, to differentiated dopaminergic SH-SY5Y cells.
Minami C; Deng Y; Maruyama W; Takahashi T; Kawai M; Nakahara D; Naoi M
J Neural Transm (Vienna); 1998; 105(4-5):397-405. PubMed ID: 9720969
[TBL] [Abstract][Full Text] [Related]
20. Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, leading to apoptosis in SH-SY5Y cells.
Yi H; Akao Y; Maruyama W; Chen K; Shih J; Naoi M
J Neurochem; 2006 Jan; 96(2):541-9. PubMed ID: 16336631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
